Sorry, we do not have enough data to show an influence graph for this author.
- Full text PDF available (0)
- This year (0)
- Last 5 years (2)
- Last 10 years (2)
Journals and Conferences
Background Riociguat, an oral soluble guanylate cyclase stimulator, is under investigation for pulmonary hypertension treatment. Cytochrome P450 (CYP)-mediated oxidative metabolism is one of the… (More)
Riociguat is a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension that is principally metabolized via the cytochrome P450 (CYP) pathway. Three studies in healthy males… (More)